Dr Ariel Cohen, Vice President of Development Projects at BiomX, blends extensive biotechnology experience with academic expertise. With a Ph.D. in Systems Biology from the Weizmann Institute of Science and a background in computational biology, he has been at the forefront of efforts to advance phage therapy as a viable treatment option for patients over the past decade. Since joining BiomX in 2018, Dr Cohen has held key leadership roles, driving development projects and strategic initiatives that support the company’s mission to harness the power of bacteriophage-based therapeutics in chronic diseases.